$18M sweet spot round size
Most of their 18 investments are in rounds between $9.9M and $27M
2007
Exosome Diagnostics raised $30M on July 24, 2017
Investors: Blue Ridge Investment Co, Forbion, Tiger Infrastructure Partners, b-to-v Partners AG and ARCUS VENTURES LTD
Exosome Diagnostics raised $16M on January 7, 2016
Investors: Forbion, Blue Ridge Investment Co, QIAGEN and ARCUS VENTURES LTD
Exosome Diagnostics raised $18M on September 2, 2015
Investors: Forbion and ARCUS VENTURES LTD
XTuit Pharmaceuticals, Inc. raised $22M on June 11, 2015
Investors: Omega Funds, Polaris Partners and ARCUS VENTURES LTD
TRACON Pharmaceuticals raised $27M on September 22, 2014
Investors: Nextech Invest, Sahsen Ventures, LLC and ARCUS VENTURES LTD
- raised $30M on July 30, 2014
Investors: RMI Partners, Domain Associates and ARCUS VENTURES LTD
Exosome Diagnostics raised $27M on March 11, 2014
Investors: b-to-v Partners AG, Forbion, QIAGEN, Tiger Infrastructure Partners and ARCUS VENTURES LTD
Undisclosed raised $3.5M on October 2, 2013
Investors: Beringea and ARCUS VENTURES LTD
T2 Biosystems raised $40M on March 28, 2013
Investors: Aisling Capital, Polaris Partners, Physic Ventures, Partners Healthcare Group, Flagship Ventures, Flybridge and ARCUS VENTURES LTD
Undisclosed raised $9.9M on March 7, 2012
Investors: Beringea and ARCUS VENTURES LTD